Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketamine for depth of anesthesia during neuromonitoring
IRCT20240507061698N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and ketamine in Spinal abnormality (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Relaxation level, Level of consciousness and 1 more. Started May 2024; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
Spinal abnormality
Beyond the preview
Go deeper on IRCT20240507061698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240507061698N1.